Abstracts Archive - Page 2467 of 2605 - ACR Meeting Abstracts

Abstract Number: 2027 • 2012 ACR/ARHP Annual Meeting
Chronic Nonbacterial Osteomyelitis of the Mandible in Children: a Tertiary Center Experience
Daniela S. Ardelean¹ and Ronald Laxer², ¹Pediatric Rheumatology, Hospital for Sick Children, Toronto, ON, Canada, ²Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada
Background/Purpose: Chronic nonbacterial osteomyelitis (CNO) of the mandible is a rare osseous autoinflammatory disease. Diagnosis is based on characteristic clinical, laboratory and imaging features. Our…
Abstract Number: 2028 • 2012 ACR/ARHP Annual Meeting
Medication Adherence and Quality of Life in Children with Rheumatic Disease
Stacey E. Tarvin¹, Lisa M. Macharoni², Christine M. Raches³ and Nicole M. Taylor², ¹Pediatric Rheumatology, Riley Hospital for Children, Indianapolis, IN, ²School of Psychological Sciences, University of Indianapolis, Indianapolis, IN, ³Riley Child Development Center, Riley Hospital for Children, Indianapolis, IN
Background/Purpose: Children with rheumatic diseases are often prescribed complex medication regimens. Medication side-effects may have a negative impact on physical appearance and subsequently impact adherence. …
Abstract Number: 2029 • 2012 ACR/ARHP Annual Meeting
Reliability of Scoring a Disease Damage Measure for Juvenile Localized Scleroderma
Kathryn S. Torok¹, Suzanne C. Li², Christina Kelsey³, Mara L Becker⁴, Fatma Dedeoglu⁵, Robert C. Fuhlbrigge⁶, Gloria Higgins⁷, Sandy D. Hong⁸, Maria F. Ibarra⁹, Ronald Laxer¹⁰, Thomas G. Mason II¹¹, Marilynn G. Punaro¹², Elena Pope¹³, C. Egla Rabinovich¹⁴ and Katie G. Stewart¹², ¹Pediatric Rheumatology, Scleroderma Center of Pittsburgh, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, ²Pediatrics, Joseph M Sanzari Children's Hospital, Hackensack University Medical Center, Hackensack, NJ, ³Pediatric Rheumatology, Univ of Pittsburgh Med Ctr, Pittsburgh, PA, ⁴Clinical Pharmacology and Rheumatology, Children's Mercy Hospital, Kansas City, MO, ⁵Division of Immunology, Boston Children's Hospital, Boston, MA, ⁶Pediatric Rheumatology, Childrens Hospital, Boston, MA, ⁷Pediatric Rheumatology NATIONWIDE CHILDRENS HOSPITAL, PRCSG-Cincinnati Children's Hospital Medical Center, Columbus, OH, ⁸Pediatrics-Rheumatology, U of Iowa Children's Hosp, Iowa City, IA, ⁹Pediatric Rheumatolgy, Children's Mercy Hospital, Kansas City, MO, ¹⁰Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, ¹¹Rheumatology, Mayo Clinic Rochester, Rochester, MN, ¹²Pediatric Rheumatology, Texas Scottish Rite Hospital, Dallas, TX, ¹³Dermatology, The Hospital for Sick Children, Toronto, ON, Canada, ¹⁴Pediatric Rheumatology, Duke University Medical Center, Durham, NC
Background/Purpose: . In order to more accurately capture disease activity and damage in juvenile Localized Scleroderma (jLS) and to develop an accepted outcome measure for…
Abstract Number: 2030 • 2012 ACR/ARHP Annual Meeting
A Multi-Modal Amplified Musculoskeletal Pain Treatment Program: Associations of Previous Pharmacotherapy with Subsequent Outcomes
Cara M. Hoffart¹, Pamela Weiss², David D. Sherry³, Chris Feudtner⁴ and Margaret Stineman⁵, ¹The Children's Hospital of Philadelphia, Philadelphia, PA, ²Center for Pediatric Clinical Effectiveness, Children's Hospital of Philadelphia, Philadelphia, PA, ³Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA, ⁴Division of General Pediatrics, Children's Hospital of Philadelphia; University of Pennsylvania Center for Clinical Epidemiology and Biostatistics, Philadelphia, PA, ⁵The University of Pennsylvania, Philadelphia, PA
Background/Purpose: Management of Amplified Musculoskeletal Pain (AMP) in children (i.e. juvenile primary fibromyalgia, complex regional pain syndrome, neuropathic pain, central sensitization) remains controversial. Common practice…
Abstract Number: 2031 • 2012 ACR/ARHP Annual Meeting
Safety and Efficacy of Anakinra in Patients with Deficiency of Interleukin-1 Receptor Antagonist
Gina A. Montealegre¹, Adriana Almeida de Jesus², Dawn C. Chapelle³, Paul Dancey⁴, Joost Frenkel⁵, Annet van Royen-Kerkhoff⁶, Ronit Herzog⁷, Giovanna Ciocca⁸, Rafael F. Rivas-Chacon⁸, Ann M. Reed⁹, Nicole Plass³, Ivona Aksentijevich¹⁰, Polly J. Ferguson¹¹, Suvimol C. Hill¹², Edward Cowen¹³ and Raphaela T. Goldbach-Mansky³, ¹NIAMS, Bethesda, MD, ²Translational Autoinflammatory Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD, ³Translational Autoinflammatory Diseases Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, MD, ⁴Health Science Centre, Memorial University of Newfoundland, St Johns, Canada, ⁵Wilhelmina Childrens Hospital, University of Utrecht, Utrecht, Netherlands, ⁶University of Utrecht, Utrecht, Netherlands, ⁷Cornell University, New York, NY, ⁸Miami Children's Hospital, Miami, FL, ⁹Rheumatology, Mayo Clinic, Rochester, MN, ¹⁰Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, ¹¹Dept of Pediatrics--Rheum, University of Iowa Carver College of Medicine, Iowa City, IA, ¹²Radiology and Imaging Sciences, NIH Clinical Center, Bethesda, MD, ¹³Dermatology Consultation Servce, National Cancer Institute, National Institutes of Health, Bethesda, MD
Background/Purpose: Deficiency of interleukin-1 receptor antagonist (DIRA) is a neonatal-onset autoinflammatory syndrome caused by mutations in IL1RN gene and clinically characterized by a perinatal onset…
Abstract Number: 2032 • 2012 ACR/ARHP Annual Meeting
Results From a Multicentre International Registry of Familial Mediterranean Fever: Impact of Genetic and Environment Factors On the Expression of a Monogenic Disease in Children
Seza Ozen¹, Erkan Demirkaya², Gayane Amaryan³, Isabelle Koné-Paut³, Adem Polat³, Turker Turker³, Patricia Woo⁴, Yosef Uziel⁵, Consuelo Modesto³, Martina Finetti³, Pierre Quartier⁶, Efimia Papadopoulou-Alataki³, Sulaiman Al-Mayouf³, Giovanna Fabio³, Romina Gallizzi⁷, Luca Cantarini⁸, Joost Frenkel⁹, Susan Nielsen¹⁰, Michael Hofer³, Antonella Insalaco³, Huri Ozdogan³, Nicolino Ruperto³ and Marco Gattorno³, ¹Hacettepe University, Ankara, Turkey, ²Gulhane Military Medical Faculty, Ankara, Turkey, ³Paediatric Rheumatology International Trials Organization (PRINTO), Istituto Giannina Gaslini, Genova, Italy, ⁴University College London, London, United Kingdom, ⁵Pediatric Rheumatology, Meir medical center, Kfar Saba, Israel, ⁶Pediatric Rheumatology, IMAGINE Institute, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Université Paris-Descartes, Paris, France, ⁷University of Messina, Messina, Italy, ⁸University of Siena, Siena, Italy, ⁹University Medical Center Utrecht, Utrecht, Netherlands, ¹⁰Istituto Giannina Gaslini, Genoa, Italy
Background/Purpose: Familial Mediterranean Fever (FMF) is an autoinflammatory disease caused by mutations in a single gene, the MEFV gene. The disease is very frequent among…
Abstract Number: 2033 • 2012 ACR/ARHP Annual Meeting
Infliximab Is an Effective Therapy in Pediatric Renal Sarcoidosis
Elisa Wershba¹, Laura Lewandowski¹, Heather Van Mater² and C. Egla Rabinovich¹, ¹Pediatric Rheumatology, Duke University Medical Center, Durham, NC, ²Duke Pediatric Rheumatology, Duke University Medical Center, Durham, NC
Background/Purpose: Renal sarcoidosis is an unusual form of a rare multisystem disease, and there is little data to guide therapy. The cytokines implicated in…
Abstract Number: 2034 • 2012 ACR/ARHP Annual Meeting
Magnetic Resonance Imaging Is a Reliable Tool to Monitor Chronic Non-Bacterial Osteomyelitis in Children
Grazia Minardo¹, Giulia Zanon¹, Simone Corradin², Pietro Zucchetta³, Giorgia Martini⁴, Fabio Vittadello¹ and Francesco Zulian⁵, ¹Department of Pediatrics, University of Padua, Padua, Italy, ²Institute of Radiology, University of Padua, Padua, Italy, ³Department of Nuclear Medicine, University of Padua, Padua, Italy, ⁴Department of Pediatrics,, University of Padua, Padua, Italy, ⁵Department of Pediatrics, University of Padua, Padova, Italy
Background/Purpose: Chronic non-bacterial osteomyelitis (CNO) is a rare condition characterized by inflammatory bone lesions with no detectable infectious agents. It may be unifocal (U-CNO) or…
Abstract Number: 2035 • 2012 ACR/ARHP Annual Meeting
Performance of Icbd (International Criteria for Behcet’s Disease) in Iranian Children with Behcet’s Disease
Nahid Shafaie¹, Bahar Sadeghi Abdollahi² and Fereydoun Davatchi², ¹Rheumatology Research Centre, Shariati Hospital-Tehran Univ, Tehran, Iran, ²Rheumatology, Behcet's Unit, Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran
Background/Purpose: ICBD is the new international criteria for diagnosis/classification of Behcet’s Disease, created in 2006. The scoring system for ICBD depends on 2 points for…
Abstract Number: 2036 • 2012 ACR/ARHP Annual Meeting
Children’s Hospital of Pittsburgh Pediatric Onset En Coup De Sabre and Parry-Romberg Syndrome Cohort
Kristin M. Brown¹, Darren Smith², Christina Kelsey³, Katherine Kurzinski⁴ and Kathryn S. Torok⁵, ¹Pediatric Rheumatology, University of Pittsburgh, Pittsburgh, PA, ²Plastic and Reconstructive Surgery, university of Pittsburgh Division of Plastic and Reconstructive Surgery, Children's Hospital of Pittsburgh, Pittsburgh, ³Pediatric Rheumatology, Univ of Pittsburgh Med Ctr, Pittsburgh, PA, ⁴Pediatric Rheumatology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, ⁵Pediatric Rheumatology, Scleroderma Center of Pittsburgh, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA
Background/Purpose: Localized scleroderma is an autoimmune disease characterized by disfiguring thickening and fibrosis of the skin and underlying soft tissues; the majority of cases have…
Abstract Number: 2037 • 2012 ACR/ARHP Annual Meeting
Poor Quality of Gout Care Is Strongly Associated with Higher Gout-Related Health Care Utilization
Jasvinder A. Singh¹ and Joshua Richman², ¹Department of Medicine, University of Alabama, Tuscaloosa, AL, ²Biostatistics, UAB School of Medicine, Birmingham, AL
Background/Purpose: Proponents of improving quality of gout care have suggested various gout quality indicators, but no study to date has shown the link between…
Abstract Number: 2039 • 2012 ACR/ARHP Annual Meeting
Uveitis Surveillance Through Lean-Six Sigma for Quality Assurance in Juvenile Idiopathic Arthritis
Anjali Patwardhan¹, Kelly Kelleher², Jeffery Hoffman³, Karla B. Jones⁴, Stacy P. Ardoin⁵ and Charles H. Spencer⁶, ¹Pediatric Rheumatology, Nationwide Childrens Hospital, Columbus, OH, ²Pediatric Research and innovation, Nationwide Childrens Hospital, Columbus, OH, ³Emergency Medicine, Nationwide Childrens Hospital, Columbus, OH, ⁴Rheumatology ED260- 2S, Nationwide Children's Hospital, Columbus, OH, ⁵Pediatric & Adult Rheumatology, Ohio State University College of Medicine, Columbus, OH, ⁶Rheumatology, Nationwide Childrens Hospital, Columbus, OH
Background/Purpose: Chronic asymptomatic iridocyclitis occurs in 10-20% of all patients with JIA leading to insidious but progressive morbidity and possible blindness. Patients with JIA-associated uveitis…
Abstract Number: 2040 • 2012 ACR/ARHP Annual Meeting
Provisions of Quality Driven Care in Childhood-Onset Systemic Lupus Erythematosus
Matthew C. Hollander¹, Jessica M. Sage², Alexandria J. Greenler², Tadej Avcin³, Michael W. Beresford⁴, Graciela Espada⁵, Marisa S. Klein-Gitelman⁶, Michael Henrickson⁷, Tsz-Leung Lee⁸, Joshua D. Pendl⁹, Marilynn G. Punaro¹⁰, Jennifer L. Huggins¹¹, Anne M. Stevens¹² and Hermine Brunner¹¹, ¹Division of Rheumatology, Seattle Children's Hospital, Seattle, WA, ²Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ³International Investigator Consortium for MAS Diagnostic Criteria, Ljubljana, Slovenia, ⁴Paediatric Rheumatology, Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom, ⁵Rheumatology Section, Childrens Hosp Ricardo Gutierrez, Buenos Aires, Argentina, ⁶Division of Rheumatology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, ⁷MLC 4010, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ⁸Paediatrics and Adolescent Med, Queen Mary Hospital, Hong Kong, Hong Kong, ⁹Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ¹⁰Pediatric Rheumatology, Texas Scottish Rite Hospital, Dallas, TX, ¹¹Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, ¹²Pediatrics, University of Washington, Seattle, WA
Background/Purpose: Quality Indicators (QI) are retrospectively measurable elements of practice performance for which there is evidence or consensus that can be used to assess the…
Abstract Number: 2000 • 2012 ACR/ARHP Annual Meeting
Whole Body Magnetic Resonance Imaging in Evaluation of Enthesitis in Spondyloarthropathy
Hemalatha Srinivasalu¹, Suvimol C. Hill², Gina A. Montealegre Sanchez³, April D. Brundidge³, Michael M. Ward⁴ and Robert A. Colbert³, ¹Rheumatology, NIAMS NIH, Bethesda, MD, ²Radiology and Imaging Sciences, NIH Clinical Center, Bethesda, MD, ³NIAMS NIH, Bethesda, MD, ⁴Bldg 10 CRC Rm 4-1339, NIAMS NIH, Bethesda, MD
Background/Purpose: Enthesitis is a characteristic feature of spondyloarthritis (SpA). Tenderness at enthesial points constitutes clinical enthesitis. However, this may not always correlate with actual inflammation…
Abstract Number: 2001 • 2012 ACR/ARHP Annual Meeting
Methotrexate and Injectable Tumor Necrosis Factor Alpha Inhibitor Adherence and Persistence in Children with Rheumatic Diseases
Sarah Ringold¹, Shannon Grant², Charmaine Girdish³, Carol A. Wallace⁴ and Sean Sullivan⁵, ¹Pediatrics, Seattle Children's Hospital/Univ of Washington, Seattle, WA, ²Axio Research LLC, Seattle, WA, ³Research, CVS Caremark, Scottsdale, AZ, ⁴Pediatrics, Seattle Childrens Hospital, Seattle, WA, ⁵Health Sciences Building, University of Washington, Seattle, WA
Background/Purpose: Medication adherence and persistence have been demonstrated to have important implications for treatment effectiveness, cost, and safety. Methotrexate is one of the most commonly…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].